Two studies investigated the role of CD8+ T cells on ridding AML caused by either mutation of nucleophosmin 1 (NPM1) or FMS-like tyrosine kinase receptor 3 internal tandem duplication (FLT3-ITD) [33,34]. This evidence concerns the gene CD8A and acute myeloid leukemia.